In Vitro Toxicology Assays Market Size, Share, Forecast to 2034

Insights into Market Size, Trends, Market Dynamics, Key Segments, and Emerging Players

Straits Research, a leading market research organization, announced the release of the report titled “In Vitro Toxicology Assays Market Size and Outlook —Forecasts till 2034”. The report provides an in-depth analysis of the market size, trends, opportunities, and market mechanism. The report also covers a regional analysis of several market factors.

According to the report, the market is valued at USD 2.2 billion in 2026, which is expected to grow to USD 4.7 billion by 2034. The projected CAGR for this period is 10.1%
The in vitro toxicology assays market is segmented based on assay type, technology, application, end use, and region. Some of the insights provided in the report are highlighted below:

The genotoxicity assays segment is expected to register a CAGR of 10.18% during the forecast period.
North America is expected to lead the market during the forecast period, owing to rapid adoption of advanced in vitro assay technologies.
Regulatory support from the US FDA and the Environmental Protection Agency for non-animal testing is accelerating the commercialization of in vitro toxicology assays.
The US is expected to lead the North America market due to increasing outsourcing of toxicology studies to CROs.

Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings.

The report is designed to enable decision makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market.